Literature DB >> 10195925

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

J S Yudkin1, C D Stehouwer, J J Emeis, S W Coppack.   

Abstract

C-reactive protein, a hepatic acute phase protein largely regulated by circulating levels of interleukin-6, predicts coronary heart disease incidence in healthy subjects. We have shown that subcutaneous adipose tissue secretes interleukin-6 in vivo. In this study we have sought associations of levels of C-reactive protein and interleukin-6 with measures of obesity and of chronic infection as their putative determinants. We have also related levels of C-reactive protein and interleukin-6 to markers of the insulin resistance syndrome and of endothelial dysfunction. We performed a cross-sectional study in 107 nondiabetic subjects: (1) Levels of C-reactive protein, and concentrations of the proinflammatory cytokines interleukin-6 and tumor necrosis factor-alpha, were related to all measures of obesity, but titers of antibodies to Helicobacter pylori were only weakly and those of Chlamydia pneumoniae and cytomegalovirus were not significantly correlated with levels of these molecules. Levels of C-reactive protein were significantly related to those of interleukin-6 (r=0.37, P<0.0005) and tumor necrosis factor-alpha (r=0.46, P<0.0001). (2) Concentrations of C-reactive protein were related to insulin resistance as calculated from the homoeostasis model assessment model, blood pressure, HDL, and triglyceride, and to markers of endothelial dysfunction (plasma levels of von Willebrand factor, tissue plasminogen activator, and cellular fibronectin). A mean standard deviation score of levels of acute phase markers correlated closely with a similar score of insulin resistance syndrome variables (r=0.59, P<0.00005), this relationship being weakened only marginally by removing measures of obesity from the insulin resistance score (r=0.53, P<0.00005). These data suggest that adipose tissue is an important determinant of a low level, chronic inflammatory state as reflected by levels of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, and that infection with H pylori, C pneumoniae, and cytomegalovirus is not. Moreover, our data support the concept that such a low-level, chronic inflammatory state may induce insulin resistance and endothelial dysfunction and thus link the latter phenomena with obesity and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195925     DOI: 10.1161/01.atv.19.4.972

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  522 in total

1.  The renaissance of C reactive protein.

Authors:  M B Pepys; A Berger
Journal:  BMJ       Date:  2001-01-06

2.  Effects of etanercept in patients with the metabolic syndrome.

Authors:  L Elizabeth Bernstein; Jacqueline Berry; Sunnie Kim; Bridget Canavan; Steven K Grinspoon
Journal:  Arch Intern Med       Date:  2006-04-24

Review 3.  CLA and body weight regulation in humans.

Authors:  Ulf Risérus; Annika Smedman; Samar Basu; Bengt Vessby
Journal:  Lipids       Date:  2003-02       Impact factor: 1.880

Review 4.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 5.  Endothelial dysfunction and the metabolic syndrome.

Authors:  Gary E McVeigh; Jay N Cohn
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 6.  Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity.

Authors:  K Esposito; G Nicoletti; D Giugliano
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

Review 7.  Endothelial dysfunction, inflammation and diabetes.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

8.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

Review 9.  Preventing diabetes by treating aspects of the metabolic syndrome.

Authors:  Roopa Sathyaprakash; Robert R Henry
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 10.  Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.

Authors:  Milagros G Huerta; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.